Taich Adaminsider trades
In SEC Form 4 filings, Taich Adam is listed as Chief Financial Officer of 10x Genomics, Inc. (TXG). In the last 90 days, Taich Adam sold $4.08M of 10x Genomics, Inc. (TXG) on the open market and bought none. 3 of the 4 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TXG10x Genomics, Inc. | Chief Financial Officer | 4 | Sep 11 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-26
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TXG10x Genomics, Inc. | Sep 9 | Sep 11 | S | 1,206 | $63.68 | Sale −$76,795 | 361,526 | Yes | Form 4 |
| TXG10x Genomics, Inc. | Sep 9 | Sep 11 | S | 31,428 | $64.31 | Sale −$2,021,125 | 330,098 | Yes | Form 4 |
| TXG10x Genomics, Inc. | Sep 9 | Sep 11 | S | 13,754 | $65.26 | Sale −$897,550 | 316,344 | Yes | Form 4 |
| TXG10x Genomics, Inc. | Aug 24 | Aug 26 | S | 17,166 | $63.02 | Sale −$1,081,853 | 362,732 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.